Anti-Human VEGF Recombinant Antibody (FD006)
CAT#: TAB-0346CL
The anti-VEGF antibody specifically target VEGF which is the most significant positive regulator of angiogenesis. The specific antibody has good biological activity, and it can inhibit vascular endothelial cell proliferation, tumor growth and corneal neovascularization. Thus the antibody can be used for the preparation of antigen-specific drugs and angiogenesis inhibiting drugs.
Published Data
ELISA
Figure 1 Antigen binding identification of FD006 to bind VEGF.
The binding activity of FD006 by ELISA.
Wang, Q., Yang, J., Tang, K., Luo, L., Wang, L., Tian, L., ... & Lv, M. (2014). Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization. BMC biotechnology, 14(1), 17.
PK
Figure 2 Antigen binding identification of FD006 to bind VEGF.
Affinity detection of FD006 by binding kinetics assays.
Wang, Q., Yang, J., Tang, K., Luo, L., Wang, L., Tian, L., ... & Lv, M. (2014). Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization. BMC biotechnology, 14(1), 17.
Inhib
Figure 3 Antigen binding identification of FD006 to bind VEGF.
The inhibitory effects of FD006 on VEGF-induced human umbilical vein endothelial cell (HUVEC) proliferation.
Wang, Q., Yang, J., Tang, K., Luo, L., Wang, L., Tian, L., ... & Lv, M. (2014). Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization. BMC biotechnology, 14(1), 17.
IHC
Figure 4 Hematoxylin and eosin (HE) staining observation of corneas.
At day 7, corneal neovascularization of various sizes (black arrowhead) were present in the superficial central corneal stroma after alkali burn (×200) and neovascularization containing RBCs in the corneal stroma were indicated with black arrowheads. Cornea stroma exhibited edema and mononuclear inflammatory response. In this plane of section, the corneal epithelium is relatively normal. Bar = 100 μm.
Wang, Q., Yang, J., Tang, K., Luo, L., Wang, L., Tian, L., ... & Lv, M. (2014). Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization. BMC biotechnology, 14(1), 17.
WB
Figure 5 The protein expression of neovascularization-related signal molecules in the cornea.
β-actin served as an internal standard. The protein expression of VEGF, MMP-9, VEGFR-1, VEGFR-2 and ICAM-1 in the cornea was significantly weaker in antibody- or dexamethasone- treated samples.
Wang, Q., Yang, J., Tang, K., Luo, L., Wang, L., Tian, L., ... & Lv, M. (2014). Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization. BMC biotechnology, 14(1), 17.
❮
❯
Specifications
- Host Species
- Human
- Type
- Human antibody
- Specificity
- Human
- Clone
- FD006
- Applications
- ELISA, PK, Inhib, IHC, WB
- Related Disease
- Colon cancer, tumor, angiogenesis
Applications
- Application Notes
- The VEGF antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Pharmacokinetic, Inhibition, Immunohistochemistry, Western Blot.
ELISA: ELISA plates were coated with 100 μl/well 0.5 μg/ml VEGF. Bevacizumab or FD006 were diluted (10, 2, 0.4, 0.08, 0.016 and 0.0032 μg/ml) and added for 2 hours' incubation in 37. After three times of washing, the Peroxidase-conjugated affinipure goat anti-human immunoglobulin G (IgG) was added as the secondary antibody for 45 minutes at room temperature. Binding signals were visualized using o-phenylenediamine dihydrochloride (OPD) substrate and the light absorbance was measured with an ELISA reader at 492 nm.
Immunohistochemistry: The rat eyeballs were harvested and fixed in 4% paraformaldehyde. The corneas were excised, embedded in paraffin, cut into 5-μm sections and then prepared for hematoxylin and eosin (H&E) staining. The cornea sections were fixed in acetone. The primary antibodies were VEGF-A, fms-like tyrosine kinase (VEGFR-1, Flt-1) and kinase insert domain receptor (VEGFR-2, Flk-1), matrix metalloproteinase-9 (MMP-9) and intercellular adhesion molecule-1 (ICAM-1). Goat anti-mouse IgG was used as the secondary antibody. Then stained samples were observed and photographed using inverted microscopy.
Western Blot: The rats were euthanized, and the corneas were harvested from the treated eyes. The corneas were dissected and frozen at -70°C, then homogenized in ice-cold RIPA lysis buffer solution. After being centrifuged for 5 minutes at 12,000 revolutions per minute (rpm), the supernatants of the samples were collected. Certain amounts of the protein were separated by electrophoresis on an 8% and 12% sodium dodecyl sulfate-polyacrylamide gel, and transferred to nitrocellulose membranes. Then the membranes were blocked using 5% skim milk in TBST (20 mM Tris, 150 mM NaCl and 0.1% Tween-20) and incubated overnight with primary antibodies: anti-VEGF, MMP-9, VEGF receptor 1, ICAM-1 and VEGF receptor 2. The secondary polyclonal antibodies were used to detect bound primary antibodies: anti-mouse, anti-rabbit, and anti-goat. After washing, an enhanced chemiluminescence solution were used to visualize specific lanes.
Target
- Alternative Names
- VEGF; Vascular endothelial growth factor
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for TAB-0346CL. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Related Diseases
Bladder Cancer
Rheumatoid Arthritis
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
Protocol & Troubleshooting
We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.
See other products for "Clone FD006"
- CAT
- Product Name
See other products for "VEGF"
Select a product category from the dropdown menu below to view related products.
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PABZ-130 | Mouse Anti-VEGF Recombinant Antibody (clone 12) | ELISA, Neut | Mouse IgG |
| PABW-130 | Mouse Anti-VEGF Recombinant Antibody (clone A4.6.1) | Neut, ELISA, Inhib, ICC, WB | Mouse IgG |
| PABC-131 | Human Anti-VEGF Recombinant Antibody (clone B20-4) | ELISA, Neut, Block | Human IgG |
| HPAB-0307LY | Human Anti-VEGF Recombinant Antibody (clone XPA.10.072) | ELISA, Inhib | Human IgG2 |
| HPAB-1377LY | Mouse Anti-VEGF Recombinant Antibody (HPAB-1377LY) | ELISA, Inhib | Mouse IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PFBZ-130 | Mouse Anti-VEGF Recombinant Antibody (clone 12); Fab Fragment | ELISA, Neut | Mouse Fab |
| PFBW-130 | Mouse Anti-VEGF Recombinant Antibody (clone A4.6.1); Fab Fragment | Neut, ELISA | Mouse Fab |
| PFBC-131 | Human Anti-VEGF Recombinant Antibody (clone B20-4); Fab Fragment | ELISA, Neut, Block | Human Fab |
| HPAB-2709LY-F(E) | Human Anti-VEGF Recombinant Antibody (clone YS03); Fab Fragment | ELISA | Human Fab |
| HPAB-AP213-YC-F(E) | Human Anti-VEGF Recombinant Antibody; Fab Fragment (HPAB-AP213-YC-F(E)) | ELISA | Human Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-285CQ | Mouse Anti-VEGF Recombinant Antibody (TAB-285CQ) | ELISA, WB, Inhib | Mouse IgG1 |
| TAB-287CQ | Mouse Anti-VEGF Recombinant Antibody (TAB-287CQ) | ELISA | Mouse IgG1, κ |
| TAB-290CQ | Anti-Human VEGF Recombinant Antibody | ELISA, WB, Neut | |
| TAB-303CQ | Anti-Human VEGF Recombinant Antibody (TAB-303CQ) | ELISA, WB, Neut | |
| TAB-285CQ-F(E) | Mouse Anti-VEGF Recombinant Antibody; Fab Fragment (TAB-285CQ-F(E)) | ELISA, WB, Neut | Mouse Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-286CQ | Anti-Human VEGF Recombinant Antibody (BD2) | ELISA, WB, Neut | Human antibody |
| TAB-291CQ | Anti-Human VEGF Recombinant Antibody (3G6) | ELISA | Human antibody |
| TAB-292CQ | Human Anti-VEGF Recombinant Antibody (TAB-292CQ) | ELISA | Human antibody |
| TAB-296CQ | Anti-Human VEGF Recombinant Antibody (XPA.10.064) | Inhib | Human antibody |
| TAB-297CQ | Anti-Human VEGF Recombinant Antibody (XPA.10.072) | Inhib | Human antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-288CQ | Human Anti-VEGF Recombinant Antibody (TAB-288CQ) | ELISA | Chimeric (Mouse/Human) IgG1, κ |
| TAB-288CQ-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (TAB-288CQ-S(P)) | ELISA, WB, IHC, Block | Human scFv |
| TAB-301CQ-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (TAB-301CQ-S(P)) | ELISA, FC, IHC, WB | Human scFv |
| PABX-185 | Recombinant Human Anti-VEGF Antibody (Fab-12) | ELISA, FuncS | IgG |
| PABX-185-F (E) | Recombinant Mouse Anti-VEGF Antibody Fab Fragment (Fab-12) | ELISA, FuncS | Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-289CQ | Human Anti-VEGF Recombinant Antibody (TAB-289CQ) | ELISA | Human IgG1, κ |
| TAB-407CQ | Human Anti-VEGF Recombinant Antibody (TAB-407CQ) | ELISA | Humanized IgG |
| TAB-408CQ | Human Anti-VEGF Recombinant Antibody (TAB-408CQ) | ELISA | Humanized IgG |
| TAB-407CQ-F(E) | Human Anti-VEGF Recombinant Antibody; Fab Fragment (TAB-407CQ-F(E)) | ELISA | Humanized Fab |
| TAB-408CQ-F(E) | Human Anti-VEGF Recombinant Antibody; Fab Fragment (TAB-408CQ-F(E)) | ELISA | Humanized Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| Gly-096LC | Recombinant Anti-Human VEGF Antibody (Fc glycosylation) | ELISA | Humanized antibody |
| Gly-143LC | Recombinant Anti-Human VEGF Antibody (Fc glycosylation) | ELISA | Humanized antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| Gly-179LC | Recombinant Anti-Human VEGF Antibody (Non-glycosylated) | ELISA | Human antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOR-4485 | Rabbit Anti-VEGF Recombinant Antibody (clone SI581DS) | ELISA | Rabbit IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-0746LY-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (HPAB-0746LY-S(P)) | ELISA | Humanized scfv |
| HPAB-1377LY-S(P) | Mouse Anti-VEGF Recombinant Antibody; scFv Fragment (HPAB-1377LY-S(P)) | ELISA, Inhib | Mouse scfv |
| HPAB-2806LY-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (HPAB-2806LY-S(P)) | ELISA, WB | Humanized scfv |
| HPAB-2807LY-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (HPAB-2807LY-S(P)) | ELISA, WB | Humanized scfv |
| HPAB-2808LY-S(P) | Human Anti-VEGF Recombinant Antibody; scFv Fragment (HPAB-2808LY-S(P)) | ELISA, WB | Humanized scfv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| HPAB-J0267-YC | Recombinant Camelid Anti-VEGF Single Domain Antibody (HPAB-J0267-YC) | ELISA, Neut | Camelid VHH |
| HPAB-J0268-YC | Recombinant Camelid Anti-VEGF Single Domain Antibody (HPAB-J0268-YC) | ELISA, Neut | Camelid VHH |
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: ELISA
Application: WB, ELISA, FC, IHC, IF, IP
Application: ELISA, Neut
Application: ELISA, IHC, IF, IP, FC, FuncS
Application: ELISA, FC
Application: ELISA, FC, Inhib, IHC-Fr, WB, IP
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
